Impact of psoriatic disease on women aged 18–45: results from a multinational survey across 11 European countries by McBride, SR, Fargnoli, MC, Fougerousse, A-C, Bustínduy, MG, Catton, L, Senturk, L, Ecoffet, C, Koren, J, Andreoli, L, Coates, LC, Titialii, A

MC1R variants as melanoma risk factors independent of at-risk phenotypic characteristics: a pooled analysis from the M-SKIP project by Tagliabue E, Gandini S, Bellocco R, Maisonneuve P, Newton-Bishop J, Polsky D, Lazovich D, Kanetsky PA, Ghiorzo P, Gruis NA, Landi MT, Menin C, Fargnoli MC, García-Borrón JC, Han J, Little J, Sera F, Raimondi S

Get full text

Assessing the Beneficial Impact of a Patient Support Program in Secukinumab-Treated Patients with Psoriasis in Italy by Argenziano G, Amerio P, Aragone MG, Baggini G, Baldari M, Castelli G, Coppola S, Costanzo A, De Pasquale R, Fargnoli MC, Foti C, Giofrè C, Lembo S, Leporati C, Loconsole F, Malara G, Peris K, Richetta AG, Savoia P, Tiberio R, Travaglini M, Uzzauto MT, Bianchi L

Get full text

Efficacy and Safety of Secukinumab in Elderly Patients with Moderate to Severe Plaque-Type Psoriasis: Post-Hoc Analysis of the SUPREME Study by Talamonti M, Russo F, Malara G, Hansel K, Papini M, Cattaneo A, Parodi A, Chiricozzi A, Malagoli P, Bardazzi F, Brazzelli V, Dapavo P, Gisondi P, Zane C, Potenza C, Cantoresi F, Fargnoli MC, Trevisini S, Brianti P, Pescitelli L, Gigante G, Bartezaghi M, Caputo L, Aloisi E, Costanzo A

Get full text

Diagnosis and treatment of basal cell carcinoma: European consensus-based interdisciplinary guidelines by Peris, K, Fargnoli, MC, Garbe, C, Kaufmann, R, Bastholt, L, Seguin, NB, Bataille, V, Marmol, VD, Dummer, R, Harwood, CA, Hauschild, A, Höller, C, Haedersdal, M, Malvehy, J, Middleton, MR, Morton, CA, Nagore, E, Stratigos, AJ, Szeimies, RM, Tagliaferri, L, Trakatelli, M, Zalaudek, I, Eggermont, A, Grob, JJ, European Dermatology Forum (EDF), the European Association of Dermato-Oncology (EADO) and the European Organization for Research and Treatment of Cancer (EORTC)

Long-Term Drug Survival and Effectiveness of Secukinumab in Patients with Moderate to Severe Chronic Plaque Psoriasis: 42-Month Results from the SUPREME 2.0 Study by Russo F, Galluzzo M, Stingeni L, Persechino S, Zichichi L, Conti A, Giofrè C, Dini V, Vispi M, Atzori L, Cattaneo A, Parodi A, Bardazzi F, Stinco G, Dapavo P, Girolomoni G, Musumeci ML, Papini M, Venturini M, Dastoli S, Di Nuzzo S, Fargnoli MC, Pagnanelli G, Bernardini N, Gambini DM, Malagoli P, Mazzatenta C, Peris K, Zalaudek I, Fabbrocini G, Loconsole F, Vassallo C, Pietroleonardo L, Prignano F, Franchi C, Offidani AM, Bonifati C, Di Lernia V, Gigante G, Bartezaghi MS, Franchi M, Ursoleo P, Aloisi E

Get full text